Product Information |
Product name |
Dapagliflozin |
CAS No. |
461432-26-8 |
Molecular Formula |
C21H25ClO6 |
Molecular Weight |
408.879 |
Quality Standard |
98% up by HPLC |
Appearance |
White to pale yellow powder |
COA of Dapagliflozin |
ITEMS |
SPECIFICATION |
RESULT |
Appearance |
White to pale yellow powder |
Conforms |
Related substance |
Purity(HPLC) ≥ 99.0% |
99.8% |
Single impurity ≤ 0.5% |
0.08% max |
|
Total impurity ≤ 1.0% |
0.2% |
|
Water |
≤ 3.0% |
1.5% |
Conclusion |
The sample meets the standard requirements |
Usage |
Dapagliflozin is a new type of antidiabetic drug, a sodium-glucose cotransporter 2 inhibitor, and the first SGLT2 inhibitor approved for the treatment of type 2 diabetes. Important choice for improving glycemic control as an adjunct to diet and exercise in adults with type 2 diabetes.